PE20121696A1 - Metodo para tratar mezclas de glicosidos con la finalidad de obtener uno a mas de estos glicosidos en una forma mas pura - Google Patents

Metodo para tratar mezclas de glicosidos con la finalidad de obtener uno a mas de estos glicosidos en una forma mas pura

Info

Publication number
PE20121696A1
PE20121696A1 PE2012001052A PE2012001052A PE20121696A1 PE 20121696 A1 PE20121696 A1 PE 20121696A1 PE 2012001052 A PE2012001052 A PE 2012001052A PE 2012001052 A PE2012001052 A PE 2012001052A PE 20121696 A1 PE20121696 A1 PE 20121696A1
Authority
PE
Peru
Prior art keywords
reb
glycosides
pure form
obtaining
solid
Prior art date
Application number
PE2012001052A
Other languages
English (en)
Spanish (es)
Inventor
Aron Erickson
John Joseph Hahn
Allan S Myerson
Andrew Keith Ohmes
Troy Allen Rhonemus
Kern M Storo
Christopher Austin Tyler
Original Assignee
Cargill Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cargill Inc filed Critical Cargill Inc
Publication of PE20121696A1 publication Critical patent/PE20121696A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L27/00Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/30Artificial sweetening agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/24Condensed ring systems having three or more rings
    • C07H15/256Polyterpene radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/24Condensed ring systems having three or more rings
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52Adding ingredients
    • A23L2/60Sweeteners
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L27/00Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/30Artificial sweetening agents
    • A23L27/33Artificial sweetening agents containing sugars or derivatives
    • A23L27/36Terpene glycosides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives
    • C07H1/06Separation; Purification
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Saccharide Compounds (AREA)
  • Seasonings (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Processing Of Solid Wastes (AREA)
  • Vaporization, Distillation, Condensation, Sublimation, And Cold Traps (AREA)
  • Extraction Or Liquid Replacement (AREA)
  • Compounds Of Unknown Constitution (AREA)
PE2012001052A 2010-01-28 2011-01-27 Metodo para tratar mezclas de glicosidos con la finalidad de obtener uno a mas de estos glicosidos en una forma mas pura PE20121696A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29916010P 2010-01-28 2010-01-28

Publications (1)

Publication Number Publication Date
PE20121696A1 true PE20121696A1 (es) 2012-12-16

Family

ID=44319766

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2012001052A PE20121696A1 (es) 2010-01-28 2011-01-27 Metodo para tratar mezclas de glicosidos con la finalidad de obtener uno a mas de estos glicosidos en una forma mas pura

Country Status (14)

Country Link
US (2) US9024012B2 (https=)
EP (1) EP2528455A4 (https=)
JP (1) JP2013518118A (https=)
KR (1) KR20120117895A (https=)
CN (2) CN102811627A (https=)
AR (1) AR080051A1 (https=)
AU (1) AU2011210818B2 (https=)
BR (1) BR112012018791A2 (https=)
CA (1) CA2788359C (https=)
MX (1) MX337550B (https=)
PE (1) PE20121696A1 (https=)
PY (1) PY1102598A (https=)
RU (1) RU2012136639A (https=)
WO (1) WO2011094423A1 (https=)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20120027363A (ko) 2009-06-16 2012-03-21 이피씨 (베이징) 내추럴 프로덕츠 컴퍼니, 리미티드 뒷맛을 감소시키거나 제거하기 위한 레바우디오사이드 d를 포함하는 조성물 및 그의 제조 방법
AU2011210818B2 (en) * 2010-01-28 2014-10-30 Cargill, Incorporated Methods to treat mixtures of glycosides to obtain one or more of these glycosides in more pure form
US20150344512A1 (en) 2011-12-19 2015-12-03 Purecircle Usa Inc. Methods of purifying steviol glycosides and uses of the same
US9578895B2 (en) 2010-08-23 2017-02-28 Epc (Beijing) Natural Products Co., Ltd. Rebaudioside A and stevioside compositions
WO2012068457A1 (en) 2010-11-19 2012-05-24 Cargill, Incorporated Method for the enrichment of rebaudioside b and/or rebaudioside d in stevia-derived glycoside compositions using adsorb-desorb chromatography with a macroporous neutral adsorbent resin
US9510611B2 (en) * 2010-12-13 2016-12-06 Purecircle Sdn Bhd Stevia composition to improve sweetness and flavor profile
US8962698B2 (en) 2011-01-28 2015-02-24 Tate & Lyle Ingredients Americas Llc Rebaudioside-mogroside V blends
KR101797644B1 (ko) * 2011-01-28 2017-11-15 테이트 앤드 라일 인그리디언츠 어메리카즈 엘엘씨 레바우디오사이드 b를 포함하는 스테비아 블렌드
ES2717431T3 (es) 2011-02-10 2019-06-21 Purecircle Usa Composición a base de estevia
US9795156B2 (en) 2011-03-17 2017-10-24 E.P.C (Beijing) Plant Pharmaceutical Technology Co., Ltd Rebaudioside B and derivatives
WO2013066490A1 (en) * 2011-09-06 2013-05-10 Pepsico, Inc. Rebaudioside d sweeteners and food products sweetened with rebaudioside d
EP4124245A1 (en) 2011-12-19 2023-02-01 The Coca-Cola Company Beverage comprising rebaudioside x
GB201217700D0 (en) 2012-08-01 2012-11-14 Tate & Lyle Ingredients Sweetener compositions containing rebaudioside B
MX2015003684A (es) 2012-09-25 2015-06-15 Cargill Inc Mezclas de esteviosidos.
HK1222515A1 (zh) 2012-12-19 2017-07-07 可口可乐公司 用於提高莱鲍迪苷x溶解度的组合物和方法
US20140171519A1 (en) 2012-12-19 2014-06-19 Indra Prakash Compositions and methods for improving rebaudioside x solubility
EP3714699B1 (en) 2013-06-07 2024-12-18 PureCircle USA Inc. Stevia extract containing selected steviol glycosides as flavor, salty and sweetness profile modifier
US10905146B2 (en) 2013-07-12 2021-02-02 The Coca-Cola Company Compositions for improving rebaudioside M solubility
CN103709215B (zh) * 2013-12-31 2016-01-06 天津北洋百川生物技术有限公司 一种从甜菊糖结晶母液糖中提取莱鲍迪甙d的方法
US10264811B2 (en) 2014-05-19 2019-04-23 Epc Natural Products Co., Ltd. Stevia sweetener with improved solubility
US10357052B2 (en) 2014-06-16 2019-07-23 Sweet Green Fields USA LLC Rebaudioside A and stevioside with improved solubilities
US10485256B2 (en) 2014-06-20 2019-11-26 Sweet Green Fields International Co., Limited Stevia sweetener with improved solubility with a cyclodextrin
EP3017708B1 (en) * 2014-10-24 2018-05-02 Red Bull GmbH Sweetening composition
US20170258121A1 (en) * 2014-11-24 2017-09-14 Cargill, Incorporated Glycoside compositions
CA2985669C (en) 2015-05-20 2022-05-03 Cargill, Incorporated Glycoside compositions
CN105037458B (zh) * 2015-07-23 2018-12-28 诸城市浩天药业有限公司 一种甜菊糖d苷晶型a、其制备方法及其应用
US11251343B2 (en) * 2017-02-08 2022-02-15 Current Lighting Solutions, Llc LED design of lower CCT utilizing PFS phosphor
EP3691468A4 (en) 2017-10-06 2021-10-20 Cargill, Incorporated EASILY SOLUBLE STEVIOL GLYCOSIDE COMPOSITIONS
CN109456371A (zh) * 2018-10-16 2019-03-12 桂林莱茵生物科技股份有限公司 一种高效甜菊糖苷混合物的制备方法
WO2020210118A1 (en) 2019-04-06 2020-10-15 Cargill, Incorporated Sensory modifiers
JP2020031640A (ja) * 2019-10-04 2020-03-05 カーギル インコーポレイテッド 配糖体混合物
WO2022132971A1 (en) * 2020-12-16 2022-06-23 Corn Products Development, Inc. Method for purifying a crude composition comprising one or more steviol glycosides

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51142570A (en) 1975-06-04 1976-12-08 Morita Kagaku Kogyo Method of imparting sweetness to food or pharmaceutical agent
JPS5262300A (en) 1975-11-13 1977-05-23 Ajinomoto Co Inc Isolation of bibaudioside-a by crystallization
JPS56121454A (en) 1980-02-27 1981-09-24 Ajinomoto Co Inc Separation of stevioside and rebaudioside a by crystallization
JPS56121453A (en) 1980-02-27 1981-09-24 Ajinomoto Co Inc Separation of stevioside and rebaudioside a
US4361697A (en) 1981-05-21 1982-11-30 F. K. Suzuki International, Inc. Extraction, separation and recovery of diterpene glycosides from Stevia rebaudiana plants
US4599403A (en) * 1985-10-07 1986-07-08 Harold Levy Method for recovery of stevioside
ATE97910T1 (de) 1987-07-21 1993-12-15 Roger H Giovanetto Verfahren zur gewinnung von steviosiden aus pflanzlichem rohmaterial.
JP3111203B2 (ja) 1987-12-26 2000-11-20 中里 隆憲 ステビア新品種に属する植物
US5962678A (en) 1996-09-13 1999-10-05 Alberta Research Council Method of extracting selected sweet glycosides from the Stevia rebaudiana plant
CN1243835A (zh) 1998-08-05 2000-02-09 黑龙江垦区海林甜菊糖有限责任公司 莱苞迪甙a提取方法
WO2006038221A1 (en) * 2004-10-04 2006-04-13 Council Of Scientific And Industrial Research Process for production of steviosides from stevia rebaudiana bertoni
US7923552B2 (en) 2004-10-18 2011-04-12 SGF Holdings, LLC High yield method of producing pure rebaudioside A
US7838044B2 (en) * 2004-12-21 2010-11-23 Purecircle Sdn Bhd Extraction, separation and modification of sweet glycosides from the Stevia rebaudiana plant
US7862845B2 (en) * 2005-10-11 2011-01-04 Purecircle Sdn Bhd Process for manufacturing a sweetener and use thereof
CN101472487B (zh) * 2006-06-19 2013-05-01 可口可乐公司 甜菊双糖苷a组合物及其纯化方法
US8791253B2 (en) 2006-06-19 2014-07-29 The Coca-Cola Company Rebaudioside A composition and method for purifying rebaudioside A
US8017168B2 (en) * 2006-11-02 2011-09-13 The Coca-Cola Company High-potency sweetener composition with rubisco protein, rubiscolin, rubiscolin derivatives, ace inhibitory peptides, and combinations thereof, and compositions sweetened therewith
CN101200480B (zh) * 2006-12-15 2011-03-30 成都华高药业有限公司 莱鲍迪甙a的提取方法
ES2381892T3 (es) 2007-01-22 2012-06-01 Cargill, Incorporated Procedimiento para producir composiciones de rebaudiósido A purificado que utiliza la cristalización disolvente/antidisolvente
CN101220062A (zh) * 2008-01-23 2008-07-16 石任兵 一种同时制备甜菊苷和莱鲍迪苷a的方法
WO2010118218A1 (en) * 2009-04-09 2010-10-14 Cargill, Incorporated Sweetener composition comprising high solubility form of rebaudioside a and method of making
AU2011210818B2 (en) * 2010-01-28 2014-10-30 Cargill, Incorporated Methods to treat mixtures of glycosides to obtain one or more of these glycosides in more pure form

Also Published As

Publication number Publication date
CN106986905B (zh) 2019-07-26
CA2788359C (en) 2019-01-08
BR112012018791A2 (pt) 2015-09-01
CA2788359A1 (en) 2011-08-04
RU2012136639A (ru) 2014-03-10
US20120289687A1 (en) 2012-11-15
CN102811627A (zh) 2012-12-05
MX337550B (es) 2016-03-10
CN106986905A (zh) 2017-07-28
EP2528455A1 (en) 2012-12-05
US9024012B2 (en) 2015-05-05
EP2528455A4 (en) 2013-11-27
AU2011210818A1 (en) 2012-08-23
AU2011210818B2 (en) 2014-10-30
PY1102598A (es) 2014-08-01
WO2011094423A1 (en) 2011-08-04
MX2012008546A (es) 2012-09-07
US20160009749A1 (en) 2016-01-14
JP2013518118A (ja) 2013-05-20
AR080051A1 (es) 2012-03-07
KR20120117895A (ko) 2012-10-24

Similar Documents

Publication Publication Date Title
PE20121696A1 (es) Metodo para tratar mezclas de glicosidos con la finalidad de obtener uno a mas de estos glicosidos en una forma mas pura
BR112015026454A2 (pt) método para a produção de um cimento de silicato de magnésio-belita-aluminato de cálcio
EA201591671A1 (ru) Аэрированные композиционные материалы, способы их получения и применения
AR093811A1 (es) Metodo para formar cristales de zeolitas tipo ddr con actividad de adsorcion estabilizada
MX2016004288A (es) Procedimiento para la purificacion de un oligosacarido neutro de leche humana usando cromatografia en lecho movil simulado.
MX2022015631A (es) Anticuerpos anti-cd40 humanizados y usos de los mismos.
ES2531212T3 (es) Procedimiento de eliminación de derivados a base de siloxano de una fase orgánica líquida
EA201690405A1 (ru) Аэрированные композиционные материалы, способы их получения и применения
PT2892808T (pt) Agregados estabilizados e outros materiais e estruturas para fins que incluem absorção de energia mas que não estão limitados à mesma
GB201521839D0 (en) Generating seismic pulses by compressive forces to map fractures
ZA201403266B (en) Prophylactic and post-acute use of progesterone to better outcomes associated with concussion
MX373528B (es) Composiciones farmacéuticas que contienen diasterómeros macrólidos, métodos para su síntesis y usos terapéuticos.
BR112014009070A2 (pt) método de síntese e intermediários úteis na preparação de pirrolobenzo-diazepinas
CL2013002743A1 (es) Cristal de anticuerpo de igg anti-esclerostina; metodo de produccion; composicion que lo comprende; y su uso para tratar desordenes oseos.
EA201491112A1 (ru) Перколированный муллит и способ его получения
UA113203C2 (xx) Спосіб модифікації бета-штукатурного гіпсу із застосуванням діетилентриамінпентаоцтової кислоти
CL2013001129A1 (es) Composicion que comprende una celula madre gbm6-ad de glioblastoma purificada; metodo de generacion de anticuerpos especificos para gbm6-ad; dicho anticuerpo; metodo para producir una vacuna de celulas dendriticas; y su uso para el tratamiento de cancer.
BR112015008908A2 (pt) uso de ivermectina e seus derivados e método para desenhar e sintetizar novos derivados
AR085919A1 (es) Moleculas de union bioespecificas que se unen a ligando 4 de tipo delta (dii4) y angiopoyetina 2 (ang2)
EA201491278A1 (ru) Модифицированный коллаген
ECSP12012157A (es) Derivados de piridina tricíclicos, medicamentos que contienen tales compuestos, su uso y proceso para su preparación
BR112015016768A2 (pt) processo para produzir etanol e furfural a partir de uma mistura de pentoses e hexoses; processo para produzir furfural a partir de uma mistura de pentoses e hexoses; processo contínuo para produzir furfural a partir de uma mistura de pentoses e hexoses; e processo contínuo para produzir furano a partir de uma mistura de pentoses e hexoses
CL2016003170A1 (es) Productos de yeso con capa de fibra de vidrio fortificada.
PT3016149T (pt) Precursor em fase de agregado para produzir uma camada de absorção de luz de uma célula solar e respetivo método de produção
CL2016000951A1 (es) Forma cristalina anhidra h de cabazitaxel; proceso de preparación; composición farmacéutica que la comprende; útil para tratar cáncer.

Legal Events

Date Code Title Description
FC Refusal